Glenn S. Kroog

Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Poster(s):

• (SLB-022) Concordance between blinded independent central review committee and physician-assessed responses: Analyses based on a real-world external control arm in relapsed/refractory multiple myeloma using IMWG data
  Monday, August 25, 2025

  11:45 AM - 12:45 PM ET

• (C-214) Second Primary Malignancy in Patients with Multiple Myeloma Receiving Chimeric Antigen Receptor T-Cell Therapy and Other Systemic Anticancer Therapy: A Comparative Study Using a Real-World Database
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET